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doi:10.1016/j.jtcvs.2007.09.01738 The Journal of Thoracic and CardiObjective: Patients who undergo an orthotopic heart transplant after explantation of an
intraperitoneal left ventricular assist device are at an increased risk of developing
diaphragmatic hernias. The aim of this study was to determine the incidence of these
hernias and to evaluate the morbidity and short-term efficacy of laparoscopic repair.
Methods: Using our prospectively maintained database, we performed a single-
institution, retrospective review of all patients who underwent laparoscopic repair
of a diaphragmatic hernia resulting from defects created by left ventricular assist
device explantation.
Results: From January 1, 1995 to March 1, 2007, 5 men at our institution (median
age, 56 years) out of 97 patients at risk developed a diaphragmatic hernia after left
ventricular assist device explantation (5.2% incidence). The median time to presen-
tation was 25.4 months (range, 9–62 months). The median size of the hernia defect
was 8 cm (range, 6–15 cm). We performed all repairs completely laparoscopically.
None of the defects were repaired primarily because doing so would have resulted
in significant tension. Instead, we secured a polytetrafluoroethylene patch over the
defect with pledget-reinforced, braided, nonabsorbable, handsewn mattress sutures,
followed by reinforcement with laparoscopic tacking screws. We noted no perioper-
ative complications. The median length of stay was 2 days (range, 1–4 days). At
a median follow-up period of 12.2 months (range, 1–31 months), no recurrences
had occurred.
Conclusion: Laparoscopic repair of diaphragmatic hernias with polytetrafluoroethy-
lene can be performed with minimal morbidity and excellent short-term results.
A
pproximately 5.2 million people in the United States are living with conges-
tive heart failure.1 Of those with end-stage congestive heart failure, an ortho-
topic heart transplant (OHT) is the most efficacious and well-established
surgical treatment. However, given the paucity of suitable donor cardiac allografts,
only 2191 people (in the United States) underwent an OHT in 2006.2 Moreover, de-
compensated heart failure often requires acute hemodynamic support. Left ventricular
assist devices (LVADs), which can provide emergency cardiovascular support that
can be continued for extended periods, are now an effective bridge to transplant,
allowing for greater than 70% survival in patients awaiting an OHT.3ovascular Surgery c January 2008
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TSAbbreviations and Acronyms
LVAD 5 left ventricular assist device
OHT 5 orthotopic heart transplant
OR 5 operating room
Depending on their design and the preference of the sur-
geon, intracorporeal LVADsmay be implanted intraperitone-
ally or extraperitoneally. With an intraperitoneal LVAD, the
locations where the inflow and outflow cannulas penetrate the
diaphragm (left laterally for inflow and anteriorly for out-
flow) are prone to herniation after LVAD explantation and
subsequent OHT (Figure 1). The reported incidence of dia-
phragmatic hernias after LVAD explantation is 4.3% (if the
cannula defects are closed at explantation) to 15.9% (if the
cannula defects are not closed at explantation).4
Experience with repair of diaphragmatic hernias resulting
from LVAD explantation is limited. Thus far, we know of
only 2 case reports of an open repair of a diaphragmatic
hernia resulting from LVAD explantation,5,6 only 1 series of
6 patients who underwent open repair,4 and only 1 case report
of a laparoscopic repair.7 The aim of our current study was to
review the incidence of diaphragmatic hernias resulting from
intraperitoneal LVAD explantation at our institution and to
evaluate the safety, perioperative outcomes, and short-term
efficacy of laparoscopic repair.
Materials and Methods
Data Collection
We obtained institutional review board approval. The need for in-
formed consent was waived.With the use of our prospectively main-
tained database, we performed a retrospective chart review for all
patients who developed a diaphragmatic hernia after LVAD explan-
tation since 1995 (the year the first LVADwas implanted in a patient
at our institution) and who subsequently underwent repair at our in-
stitution. We excluded patients from our analysis who were not at
a significant risk for developing a diaphragmatic hernia because
they did not undergo LVAD explantation (patients who had an
LVAD placed as permanent [destination] therapy and patients
who did not survive to undergo an OHT) or because they had under-
gone implantation of an extracorporeal or intracorporeal extraperito-
neal LVAD. We collected data on patient characteristics,
perioperative details, and early follow-up findings. The date of dia-
phragmatic hernia diagnosis was defined as the date on which the
results of an imaging study (chest x-ray, computed tomographic
scan, or upper gastrointestinal series) confirmed the presence of
a hernia. Repair failure was defined by computed tomography
evidence of recurrence.
Statistical Analysis
We report the results as the median with the range in parentheses or
the mean 6 standard deviation, where appropriate. With the use of
the Statistical Package for the Social Sciences 14.0 for Windows
(SPSS Inc, Chicago, Ill), we compared our results with those ofThe Journal of Tha previous study from another institution on the outcomes of open
repair of diaphragmatic hernias after LVAD explantation,4 using
a 2-sample t test for continuous variables (a 5 0.05) and Fisher
exact test for categoric variables (a 5 0.05).
Results
Hernia Incidence
From January 1, 1995 to March 1, 2007, we implanted a
total of 288 heart assist devices in 230 patients (Figure 2).
Of the 97 patients who later underwent explantation of an
intraperitoneal LVAD, 5 developed a diaphragmatic hernia
(5.2% incidence) (Figure 3). During implantation of an intra-
peritoneal LVAD, our cardiac surgeons create discrete de-
fects in the diaphragm for the inflow and outflow cannulas
(Figure 1). Because we close the diaphragmatic cannula de-
fects at the time of LVAD explanation, we compared the
hernia incidence in our patients with that reported in the
literature when the defects are closed at the time of LVAD
explantation (4.3%).4 The hernia incidence in our patients
and the reported incidence in the literature were similar
(P 5 .68).
Patient Characteristics
Five men (median age, 56 years) developed a diaphragmatic
hernia after LVAD explantation, even though their diaphrag-
matic cannula defects had been closed at the time of their
LVAD explantation and subsequent OHT (Table 1). Two pa-
tients developed a hernia through the inflow cannula defect,
and 3 patients developed a hernia through the outflow can-
nula defect. For all 5 patients, induction immunosuppression
included a steroid taper; for maintenance immuno-
suppression, all 5 patients were receiving mycophenolate
mofetil and tacrolimus.8 None of the 5 patients were taking
long-term steroids. The time to presentation after their
OHT varied widely (median, 25.4; range, 9–62.3 months)
(Table 1). All 5 patients had developed upper abdominal or
lower chest discomfort. Other hernia symptoms included
bloating (2 patients), borborygmi (2 patients), and nausea
(1 patient). Because of worsening pain, 1 patient required
urgent repair.
Perioperative Details
The omentum, colon, and stomach were the most common
viscera within the hernia sac (Table 1). The median size of
the defect was 8 cm (range, 6–15 cm). None of the defects
were repaired primarily because doing so would have re-
sulted in significant tension. Instead, we secured a 2-mm
polytetrafluoroethylene patch (Gore Dualmesh, WL Gore &
Associates Inc, Flagstaff, Ariz) over the defect using pled-
get-reinforced, braided, nonabsorbable, handsewn mattress
sutures, followed by reinforcement with laparoscopic tacking
screws. The median operating room (OR) time was 219
minutes (range, 182–345 minutes). However, most patients
required extensive adhesiolysis. For instance, 1 patientoracic and Cardiovascular Surgery c Volume 135, Number 1 39
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TSFigure 1. Coronal view (A) (adaptedwith
permission from Thoratec Corp, Pleasan-
ton, Calif) and axial view (B) (adapted
from Gray's Anatomy of the Human
Body, 20th Ed, accessed from http://en.
wikipedia.org/wiki/Image:Gray391.png)
demonstrating the relationship of the
LVAD inflow and outflow cannulas to
the diaphragm. LVAD, left ventricular
assist device.required 3 hours of adhesiolysis to free his colon from the
surface of his cardiac allograft. Blood loss was minimal
(median, 50 mL; range 20–50 mL). We noted no periopera-
tive complications. Postoperatively, all 5 patients were able
to resume oral intake immediately and had a short length of
stay (mean, 2.66 1.3 days) (Table 1). Compared with a pub-
lished series of open repair of diaphragmatic hernias resulting
from LVAD explanation (mean length of stay, 7.8 6 2.240 The Journal of Thoracic and Cardiovascular Surgery c Januadays),4 the length of stay in our series of laparoscopic repair
was significantly shorter (P 5 .001).
Early Follow-up
At a median follow-up time of 12.2 months (range, 1–31
months) (Table 1), none of our patients had radiographic
evidence of hernia recurrence (Figure 4). All 5 patients were
seen for routine follow-up at our institution’s cardiacTotal Patients
(n = 230)
Destination
Therapy
(n = 26)
Bridge to
Transplantation
or Recovery
(n = 204) 
Extracorporeal
VAD
(n = 23)
Intracorporeal
Extraperitoneal
LVAD
(n = 60)
Intracorporeal
Intraperitoneal 
LVAD
(n = 121) 
Did Not Undergo
Explantation
(n = 32)
Did Not Undergo
Explantation
(n = 24)
Underwent
Explantation
(n = 97)
STUDY GROUP
Underwent
Explantation
(n = 28)
Alive
(n = 22)
Deceased
(n = 10)
Alive
(n = 3)
Deceased
(n = 21)
Figure 2. Distribution of extracorporeal
VADs and intracorporeal LVADs per-
formed at the University of Minnesota
from January 1, 1995, to March 1, 2007.
VAD, Ventricular assist device; LVAD,
left ventricular assist device.ry 2008
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TSFigure 3. Axial (A) and coronal (B) views of a
preoperative computed tomographic scan in a
patient with a diaphragmatic hernia after LVAD
explantation (arrows point to hernia).Gtransplant and thoracic surgery clinics. At a median follow-
up time of 18.7 months (range, 1.2–37.2 months), all 5 pa-
tients were symptom-free.
Discussion
At our institution, the incidence of diaphragmatic hernias af-
ter patients underwent both LVAD explantation and closure
of their cannula defects (5.2%) is consistent with the inci-
dence reported in the only other series in the literature
(4.3%).4 Even though all 5 such patients in our series under-
went closure of their cannula defects at the time of their
LVAD explantation and were not receiving long-term ste-
roids, all 5 patients nonetheless developed a diaphragmatic
hernia. We know that even steroid-free maintenance immu-
nosuppression can contribute to poor healing of the dia-
phragm after closure of cannula defects.8The Journal of ThoNote that all of the patients in the aforementioned only
other series in the literature4 underwent intraperitoneal
LVAD placement. In our study, we hypothesized that the
risk of diaphragmatic hernias would be much higher after ex-
plantation of an intraperitoneal (vs extraperitoneal) LVAD.
Therefore, to minimize bias when comparing our results
with the other series (in which patients underwent open re-
pair),4 we excluded from our analysis patients who under-
went explantation of an extraperitoneal LVAD. We found
that the proportion of patients who developed a diaphragmatic
hernia after explantation of an extraperitoneal LVAD (0 of 28
patients) was lower than after explantation of an intraperito-
neal LVAD (5 of 97 patients). However, this difference was
not statistically significant (Fisher exact test, P 5 .59). Our
inability to detect a significant difference may be due to
a type II error. Because a relatively small number ofTABLE 1. Characteristics of patients who underwent laparoscopic repair of diaphragmatic hernia after left ventricular
assist device explanation
Patient
Age
(y) Sex Diagnosis
Duration of
LVAD use before
OHT (mo)
Repair of cannula
defects at
OHT
Time to
presentation
after OHT (mo)
Size of
defect (cm)
Location of
hernia Contents
LOS
(d)
Follow-up
(mo)
1 57 M Ischemic
cardiomyopathy
3.1 Primary 62.3 6.0 Outflow cannula
defect
Omentum,
stomach
1 30.8
2 45 M Idiopathic
cardiomyopathy
3.8 Primary 26.3 6.0 Outflow cannula
defect
Omentum,
colon
4 12.5
3 65 M Ischemic
cardiomyopathy
14.7 Primary 25.4 15.0 Outflow cannula
defect
Omentum,
colon
2 11.9
4 18 M Familial
cardiomyopathy
1.8 Primary 9.0 8.0 Inflow cannula
defect
Omentum,
stomach
2 6.5
5 56 M Idiopathic
cardiomyopathy
13.0 Mesh 23.7 13.0 Inflow cannula
defect
Omentum,
colon,
small
intestine
4 1.1
Median 56 6.8 25.4 8.0 2 12.2
LVAD, Left ventricular assist device; OHT, orthotopic heart transplant; LOS, length of stay.racic and Cardiovascular Surgery c Volume 135, Number 1 41
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TSFigure 4. Axial (A) and coronal (B) views of a post-
operative computed tomographic scan in the
same patient, demonstrating a durable hernia
repair (arrow points to polytetrafluoroethylene
patch).extraperitoneal LVADs have been explanted at our institu-
tion, our study may lack sufficient statistical power to detect
a significant difference.
Clearly, if the peritoneum is violated, diaphragmatic her-
nias can and do occur after explantation of an intracorporeal
extraperitoneal LVAD. Of the 14 patients reported in the lit-
erature who developed a diaphragmatic hernia after LVAD
explantation4-7 (as well in as our series), only 1 developed
a diaphragmatic hernia after explantation of an extraperito-
neal LVAD.7 In the future, as more patients with extraperito-
neal LVADs undergo explantation, a more accurate
assessment of the risk of diaphragmatic hernias may be pos-
sible. Regardless of whether an LVAD is placed intraperito-
neally or extraperitoneally, the diaphragmatic defects should
be repaired at the time of explantation, given the significant
risk (15.9%)4 and the associatedmorbidity of a diaphragmatic
hernia if such defects are not immediately repaired. Unless
the risk of infection is prohibitively high, mesh should be
used to repair large cannula defects.
The time to diagnosis of diaphragmatic hernias after
LVAD explantation varies widely: from 6 months to more
than 60 months after OHT.4,5,7 Consequently, all patients
who undergo OHT and intraperitoneal LVAD explantation,
and who develop upper abdominal pain or anterior chest dis-
comfort should undergo imaging (ie, chest x-ray or computed
tomography) to evaluate for the presence of a diaphragmatic
hernia, regardless of whether or not their diaphragmatic
cannula defects were closed at the time of their OHT.
Diaphragmatic hernias after LVAD explantation were first
described in 1992.5 Since then, only 4 other reports have dis-
cussed the presenting symptoms and the outcomes after re-
pair of these hernias, despite the burgeoning use of LVADs
and presumably a growing prevalence of these hernias.4-7
Moreover, little attention has been devoted to the technical
aspects of repairing these hernias. Because of the large size
of the hernias in our study (median, 8 cm), a polytetrafluoro-
ethylene patch was required to perform a tension-free repair.42 The Journal of Thoracic and Cardiovascular Surgery c JanuTo secure the patch over the defect, we used pledget-rein-
forced, 0 silk, handsewn mattress sutures on an SH needle
and then reinforced the repair with laparoscopic tacking
screws to close any potential small gaps between the sutures.
We prefer these handsewn stitches to automatic laparoscopic
stitching devices because the SH needle allows deeper and
wider tissue bites under direct visualization. Theoretically,
the pledgets could erode through the diaphragm or into other
viscera, but we have not encountered this complication in this
series or in our previous series of laparoscopic repair of giant
hiatal hernias (in which a crural repair was performed with
a similar stitch).9
The few reports in the literature of diaphragmatic hernias
after LVAD explantation did not describe the OR time.
Compared with the OR time of reports in the literature of
laparoscopic repair of traumatic diaphragmatic hernias
(range, 55–200 minutes), our OR time (range, 182–345
minutes) was longer.10,11 However, repair of diaphragmatic
hernias after LVAD explantation can be technically chal-
lenging. For instance, several of our 5 patients required me-
ticulous adhesiolysis to separate herniated viscera from their
cardiac allografts. Despite the technical challenges, we be-
lieve that laparoscopic repair has several distinct advantages:
(1) reduced immunologic stress, compared with laparot-
omy;12-14 (2) better visualization and mobilization of the
hernia sac in the mediastinum, thereby sparing the patient
a thoracoscopy or thoracotomy; (3) earlier resumption of
oral intake, allowing patients to continue their immunosup-
pression without interruption; (4) shorter length of stay,
compared with open repair; and (5) better cosmesis, com-
pared with laparotomy.
Conclusions
Laparoscopic repair of diaphragmatic hernias resulting from
vulnerable locations in the diaphragm created by LVAD ex-
plantation can be performed with minimal morbidity, a brief
length of stay, and excellent short-term results.ary 2008
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